| Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (NCT02068586) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-11-19 |
| Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases (NCT01730157) | Case Comprehensive Cancer Center | 2012-12-01 |
| Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye (NCT01413191) | National Cancer Institute (NCI) | 2011-08-01 |
| Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye (NCT00329641) | National Cancer Institute (NCI) | 2011-02-01 |
| Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance (NCT01100528) | Case Comprehensive Cancer Center | 2009-11-11 |
| VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00450255) | National Cancer Institute (NCI) | 2007-06-01 |
| AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma (NCT00243061) | National Cancer Institute (NCI) | 2006-01-01 |
| Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma (NCT00288041) | National Cancer Institute (NCI) | 2005-10-01 |
| Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma (NCT00121225) | National Cancer Institute (NCI) | 2005-09-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma (NCT00089063) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma (NCT00085189) | University of Southern California | 2004-05-01 |